130,940€
-1,92%
Echtzeit-Aktienkurs Merck & Co
Bid:
Ask:
Anlagetrends der Merck & Co Aktie
Diabetes
Der Pharmakonzern produziert den Blockbuster Januvia zur Behandlung von Typ 2 Diabetes.
Sektor: Medizin / Pharmaunternehmen
| Abbott Laboratories | - | 101,30€ | -1,94 % | ||
| ABBVIE | - | 256,95€ | -1,59 % | ||
| Agile Therapeutics | - | 0,60$ | 11,52 % | ||
| Akorn Inc. | - | - | - | ||
| Alcon | - | 76,54$ | -1,00 % | ||
| ASTRAZENECA DL-,25 SP.ADR | - | 92,83$ | 0,26 % | ||
| AstraZeneca PLC | - | 166,55€ | -1,01 % | ||
| Baxter International | - | 22,86€ | -3,54 % | ||
| BAYER AG NA O.N. | 9 | 55,45€ | 2,23 % | ||
| BIOTEST AG VZ O.N. | - | 29,50€ | -0,67 % | ||
| Bristol-Myers Squibb Co | - | 56,28€ | -1,18 % | ||
| Cumberland Pharmaceuticals | - | 5,02$ | 13,06 % | ||
| DERMAPHARM HLDG INH O.N. | - | 38,55€ | -0,90 % | ||
| Eagle Pharmaceuticals | - | 1,92€ | -0,78 % | ||
| Eli Lilly & Co | 2 | 1.218,50€ | -3,86 % | ||
| Endo International PLC | - | 0,29€ | -6,77 % | ||
| GRIFOLS SA INH. A EO-,25 | - | 11,16€ | -0,65 % | ||
| GSK plc | - | 39,90€ | -1,72 % | ||
| GSK PLC LS-,25 | - | 16,77€ | -17,24 % | ||
| HEIDELBERG PHARMA AG O.N. | - | 2,12€ | 4,44 % | ||
| Johnson & Johnson | - | 242,88€ | -1,43 % | ||
| Lannett Co. Inc. | - | 0,58€ | -9,38 % | ||
| Merck & Co | - | 130,96€ | -2,01 % | ||
| Nature's Sunshine Products | - | 10,26$ | -20,09 % | ||
| Novartis AG | - | 144,50€ | -1,70 % | ||
| NOVARTIS NAM. SF 0,49 | - | 132,18CHF | -1,55 % | ||
| Novo-Nordisk A/S | - | 35,90€ | -4,67 % | ||
| Pfizer | 8 | 26,64€ | -2,83 % | ||
| ROCHE HLDG AG INH. SF 1 | - | 392,91CHF | -2,16 % | ||
| Rockwell Medical Inc | - | 7,70$ | -4,35 % | ||
| Sanofi ADS | - | 41,90€ | -0,24 % | ||
| SANOFI SA INHABER EO 2 | - | 83,82€ | -0,33 % | ||
| Taro Pharmaceutical Industries Ltd | - | 42,97$ | 0,00 % | ||
| TEVA PHARMACEUT. SP.ADR | 1 | 37,10$ | 2,06 % | ||
| ZOETIS | - | 73,22€ | -6,82 % | ||